Biogen | Lucro Operacional

Preço das Ações
192.03
Mudança Diária
-0.05 -0.03%
Mensal
11.24%
Anual
36.54%
Q1 Previsão
190.43




Lucro Operacional Alterar Data
AbbVie USD 5.81B 1.23B 2025-12
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
ALKERMES USD 89.08M 3.9M 2025-09
Amgen USD 3.96B 464M 2025-12
Bayer EUR -543M 556M 2025-09
Biogen USD 659.6M 192.2M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Esperion Therapeutics USD -16.03M 18.6M 2024-09
Gilead Sciences USD 2.96B 551M 2025-12
Incyte USD 383.88M 47.43M 2025-12
Merck USD 6.24B 318M 2025-12
Moderna USD -857M 597M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD 4.5B 363M 2025-09
Pfizer USD 4.65B 3.99B 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD 22.08M 24.26M 2024-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 1.7B 2.17B 2025-12
Sanofi EUR 1.5B 2.29B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Teva Pharmaceutical Industries USD 487M 581M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
United Therapeutics USD 389.3M 112.4M 2025-09
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12


Biogen Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.